Retinoblastoma loss modulates DNA damage response favoring tumor progression

• Published in: PloS one 2008-11, Vol.3 (11), p.e3632-e3632
• Main Authors: Seoane, Marcos, Iglesias, Pablo, Gonzalez, Teresa, Dominguez, Fernando, Fraga, Maximo, Aliste, Carlos, Forteza, Jeronimo, Costoya, Jose A
• Format: Article
• Language: English
• Subjects: Animals; Animals, Newborn; Apoptosis; Astrocytes - metabolism; Astrocytes - pathology; Astrocytes - physiology; Brain tumors; Cancer; Cancer prevention; Cell activation; Cell Biology/Neuronal and Glial Cell Biology; Cell cycle; Cell Proliferation; Cell Transformation, Neoplastic - genetics; Cells, Cultured; Deactivation; Deoxyribonucleic acid; Dephosphorylation; Deregulation; Development and progression; Disease Progression; DNA; DNA damage; DNA Damage - physiology; DNA repair; Feedback; Gene expression; Gene loci; Genes, ras - physiology; Genetic transformation; Genomes; Glioma; Gliomas; Growth factors; Humans; Inactivation; Kinases; Lesions; Medical prognosis; Mice; Mice, SCID; Models, Biological; Molecular Biology; Mutation; Neoplasms - genetics; Neoplasms - pathology; Neovascularization, Pathologic - genetics; Neovascularization, Pathologic - pathology; Oncology; Phosphatase; Phosphatases; Phosphorylation; Proteins; Retina; Retinoblastoma; Retinoblastoma Protein - genetics; Retinoblastoma Protein - metabolism; Retinoblastoma Protein - physiology; Senescence; Signal transduction; Transformation; Transplantation, Heterologous; Tumor Burden - genetics; Tumorigenesis; Tumors; Ultraviolet radiation
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0003632

Senescence is one of the main barriers against tumor progression. Oncogenic signals in primary cells result in oncogene-induced senescence (OIS), crucial for protection against cancer development. It has been described in premalignant lesions that OIS requires DNA damage response (DDR) activation, safeguard of the integrity of the genome. Here we demonstrate how the cellular mechanisms involved in oncogenic transformation in a model of glioma uncouple OIS and DDR. We use this tumor type as a paradigm of oncogenic transformation. In human gliomas most of the genetic alterations that have been previously identified result in abnormal activation of cell growth signaling pathways and deregulation of cell cycle, features recapitulated in our model by oncogenic Ras expression and retinoblastoma (Rb) inactivation respectively. In this scenario, the absence of pRb confers a proliferative advantage and activates DDR to a greater extent in a DNA lesion-independent fashion than cells that express only HRas(V12). Moreover, Rb loss inactivates the stress kinase DDR-associated p38MAPK by specific Wip1-dependent dephosphorylation. Thus, Rb loss acts as a switch mediating the transition between premalignant lesions and cancer through DDR modulation. These findings may have important implications for the understanding the biology of gliomas and anticipate a new target, Wip1 phosphatase, for novel therapeutic strategies.